Youbin Liu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
-
- Mitochondrial Function and Pathology 2
- Co-authors
- Guangnan Li (4 shared papers)Bo Yu (5 shared papers)Huimin Lu (2 shared papers)Jinwei Tian (3 shared papers)Xing Ming (1 shared paper)Wei Li (1 shared paper)Xianglu Li (1 shared paper)Bo Yu (1 shared paper)
- Journals
- Frontiers in Cardiovascular Medicine (3 papers)The FASEB Journal (2 papers)Journal of the American Heart Association (2 papers)Gene (1 paper)Frontiers of Chemical Science and Engineering (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Youbin Liu
24 papers receiving 398 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 166
- Geriatrics and Gerontology 11
- Cardiology and Cardiovascular Medicine 61
- Molecular Biology 199
- Pathology and Forensic Medicine 29
Countries citing papers authored by Youbin Liu
This map shows the geographic impact of Youbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youbin Liu more than expected).
Fields of papers citing papers by Youbin Liu
This network shows the impact of papers produced by Youbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youbin Liu. The network helps show where Youbin Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Youbin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 85 | |
| 2 | 2014 | 59 | |
| 3 | 2017 | 33 | |
| 4 | 2018 | 30 | |
| 5 | 2016 | 29 | |
| 6 | 2021 | 26 | |
| 7 | 2015 | 24 | |
| 8 | 2020 | 20 | |
| 9 | 2014 | 13 | |
| 10 | 2016 | 13 | |
| 11 | 2018 | 12 | |
| 12 | 2019 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2016 | 3 |
About Youbin Liu
Youbin Liu is a scholar working on Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine, Pharmacology and Immunology, having authored 24 papers that have together received 400 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Mitochondrial Function and Pathology (2 papers), MicroRNA in disease regulation (2 papers), Cardiac Imaging and Diagnostics (1 paper), Galectins and Cancer Biology (1 paper), Gout, Hyperuricemia, Uric Acid (1 paper), Coronary Interventions and Diagnostics (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (166 citations), Geriatrics and Gerontology (11 citations), Cardiology and Cardiovascular Medicine (61 citations), Molecular Biology (199 citations) and Pathology and Forensic Medicine (29 citations). Youbin Liu has collaborated with scholars based in China, United States and India. Frequent co-authors include Guangnan Li, Bo Yu, Huimin Lu, Jinwei Tian, Xing Ming, Wei Li, Xianglu Li, Bo Yu, Xingda Li and Tianyu Li. Their work appears in journals such as Frontiers in Cardiovascular Medicine, The FASEB Journal, Journal of the American Heart Association, Gene and Frontiers of Chemical Science and Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.